CIK 0001604821
- Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010894487
- Phone
- +1 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-15 | BOTHA ROELOF Director | Exercise or conversion · Stock Option (right to buy) | −884 | 0 | ||
| 2024-03-15 | BOTHA ROELOF Director | Exercise or conversion · Stock Option (right to buy) | −851 | 0 | ||
| 2024-03-15 | BOTHA ROELOF Director | Exercise or conversion · Stock Option (right to buy) | −793 | 0 | ||
| 2024-03-15 | BOTHA ROELOF Director | Exercise or conversion · Stock Option (right to buy) | −607 | 0 | ||
| 2024-03-15 | BOTHA ROELOF Director | Exercise or conversion · Stock Option (right to buy) | −687 | 0 | ||
| 2024-03-15 | BOTHA ROELOF Director | Exercise or conversion · Stock Option (right to buy) | −807 | 0 | ||
| 2024-03-15 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion 10b5-1 | +21,865 | $13.01 | $284K | 268,822 |
| 2024-03-15 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion 10b5-1 | +27,655 | $20.27 | $561K | 296,477 |
| 2024-03-15 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion 10b5-1 | +18,750 | $25.46 | $477K | 315,227 |
| 2024-03-15 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −19,929 | $87.96 | $1.8M | 295,298 |
| 2024-03-15 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −34,960 | $88.98 | $3.1M | 260,338 |
| 2024-03-15 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −28,334 | $89.63 | $2.5M | 232,004 |
| 2024-03-15 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −21,865 | 2,084 | ||
| 2024-03-15 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −27,655 | 3,595 | ||
| 2024-03-15 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −18,750 | 0 | ||
| 2024-03-07 | Sheena Jonathan Director | Gift | −110,854 | 347,731 | ||
| 2024-03-07 | Sheena Jonathan Director | Gift | +55,427 | 70,082 | ||
| 2024-03-07 | Sheena Jonathan Director | Gift | +55,427 | 70,082 | ||
| 2024-03-06 | Sheena Jonathan Director | Sale 10b5-1 | −3,184 | $88.45 | $282K | 460,401 |
| 2024-03-06 | Sheena Jonathan Director | Sale 10b5-1 | −1,816 | $89.13 | $162K | 458,585 |
Page 77 of 85 · 1,682 trades